| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 07/26/2000 | CN1261353A Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p561ck tyrosine kinases |
| 07/26/2000 | CN1261349A Chalcones having antiproliferactive activity |
| 07/26/2000 | CN1261281A Peptide parathyroid hormone analogs |
| 07/26/2000 | CN1261278A Methods for treating inflammatory diseases using padprt inhibitors |
| 07/26/2000 | CN1261277A Novel substituted imidazole compounds |
| 07/26/2000 | CN1261276A Protease inhibitors |
| 07/26/2000 | CN1261274A Carboxylic acids and derivatives thereof and pharmaceutical compositions containing them. |
| 07/26/2000 | CN1054856C New 19-nor steroids having phenoxyalkylsulphonemide or phenoxyalkylsulphonylurea chain in position llbeta, preparation process and intermediates, use as medicaments and pharmaceutical |
| 07/26/2000 | CN1054848C New benzopyran derivatives, their process of preparation and pharmaceutical compositions |
| 07/26/2000 | CN1054846C Use of intermediates for production of aromatic aminoalcohol derivatives having anti-diabetic and anti-obesity properties |
| 07/26/2000 | CN1054773C Chinese patent drug 'Bizhengning' for treatment of arthralgia-syndrome |
| 07/26/2000 | CN1054772C Quick-acting Duangusan powder capable of setting of fracture in 2-6 hours |
| 07/26/2000 | CN1054770C Chinese proprietary medicine for protrusion of intervertebral disc |
| 07/26/2000 | CN1054754C Medicinal composite for rheumatism |
| 07/26/2000 | CN1054742C Improvements in or relating to benzothiophenes |
| 07/25/2000 | US6093743 Therapeutic methods employing disulfide derivatives of dithiocarbamates and compositions useful therefor |
| 07/25/2000 | US6093710 Benzothiophene derivatives, their preparation and use as urokinase inhibitors |
| 07/25/2000 | US6093696 N-acetyl-d-thioproline-(o-2,6-dichlorobenzyl)-l-tyrosine, for example; selectively inhibit the alpha 4 subgroup of integrins from binding to their ligands; use in prophylaxis or treatment of immune or inflammatory diseases |
| 07/25/2000 | US6093561 Human lysophospholipase |
| 07/20/2000 | WO2000042429A2 In vitro model for gastrointestinal inflammation |
| 07/20/2000 | WO2000042216A2 Genetic predisposition to abnormal calcification conditions |
| 07/20/2000 | WO2000042213A1 A novel method for designing protein kinase inhibitors |
| 07/20/2000 | WO2000042211A1 Methods of screening protease inhibitors, of inducing mice susceptible to hiv protease inhibitor-induced dyslipidemia, and genes associated therewith |
| 07/20/2000 | WO2000042172A2 Human homologues of proteins regulated by circadian rhythms |
| 07/20/2000 | WO2000042168A2 Bifidobacterium in the treatment of inflammatory disease |
| 07/20/2000 | WO2000042071A2 Compounds and methods to inhibit or augment an inflammatory response |
| 07/20/2000 | WO2000042070A1 Mammalian alpha-helical protein - 12 |
| 07/20/2000 | WO2000042069A1 Bone stimulating factor |
| 07/20/2000 | WO2000042054A1 2,3-o-isopropylidene derivatives of monosaccharides as cell adhesion inhibitors |
| 07/20/2000 | WO2000042042A2 High affinity inhibitors for target validation and uses thereof |
| 07/20/2000 | WO2000042031A2 Substituted 2-arylimino heterocycles and compositions containing them, for use as progesterone receptor binding agents |
| 07/20/2000 | WO2000042029A1 1-heterocycle substituted diarylamines |
| 07/20/2000 | WO2000042023A1 Substituted imidazoles, their preparation and use |
| 07/20/2000 | WO2000042022A1 Benzoheterocycles and their use as mek inhibitors |
| 07/20/2000 | WO2000042020A1 Phenylphenanthridines with pde-iv inhibiting activity |
| 07/20/2000 | WO2000042018A1 Polysubstituted 6-phenylphenanthridines with pde-iv inhibiting activity |
| 07/20/2000 | WO2000042003A1 Benzenesulfonamide derivatives and their use as mek inhibitors |
| 07/20/2000 | WO2000042002A1 Sulphohydroxamic acids and sulphohydroxamates and their use as mek inhibitors |
| 07/20/2000 | WO2000041994A1 4-arylamino, 4-aryloxy, and 4-arylthio diarylamines and derivatives thereof as selective mek inhibitors |
| 07/20/2000 | WO2000041725A2 Therapeutic compositions for metabolic bone disorders or bone metastases |
| 07/20/2000 | WO2000041724A1 Modulation of systemic memory t cell trafficking |
| 07/20/2000 | WO2000041707A2 USE OF $i(LACTOBACILLUS SALIVARIUS) |
| 07/20/2000 | WO2000041669A2 Benzimidazole vascular damaging agents |
| 07/20/2000 | WO2000041566A1 Regulation of endogenous gene expression in cells using zinc finger proteins |
| 07/20/2000 | WO2000041545A2 Regulators of the pct or smoothened pathway, compositions and uses related thereto |
| 07/20/2000 | WO2000041505A2 Anthranilic acid derivatives |
| 07/20/2000 | WO2000041469A2 β-PHENYLALANINE DERIVATIVES AS INTEGRIN ANTAGONISTS |
| 07/20/2000 | WO2000014097A3 Novel pyranoses |
| 07/20/2000 | CA2724287A1 Bifidobacterium in the treatment of inflammatory disease |
| 07/20/2000 | CA2697598A1 Compounds and methods to inhibit or augment an inflammatory response |
| 07/20/2000 | CA2370042A1 Regulators of the pct or smoothened pathway, compositions and uses related thereto |
| 07/20/2000 | CA2360588A1 Human homologues of proteins regulated by circadian rhythms |
| 07/20/2000 | CA2360584A1 Mammalian alpha-helical protein - 12 |
| 07/20/2000 | CA2360581A1 A novel method for designing protein kinase inhibitors |
| 07/20/2000 | CA2360386A1 Polysubstituted 6-phenylphenanthridines with pde-iv inhibiting activity |
| 07/20/2000 | CA2360356A1 .beta.-phenylalanine derivatives as integrin antagonists |
| 07/20/2000 | CA2360243A1 Use of lactobacillus salivarius |
| 07/20/2000 | CA2359986A1 2,3-o-isopropylidene derivatives of monosaccharides as cell adhesion inhibitors |
| 07/20/2000 | CA2359798A1 Methods of screening protease inhibitors, of inducing mice susceptible to hiv protease inhibitor-induced dyslipidemia, and genes associated therewith |
| 07/20/2000 | CA2359562A1 Substituted 2-arylimino heterocycles and compositions containing them, for use as progesterone receptor binding agents |
| 07/20/2000 | CA2358908A1 Bone stimulating factor |
| 07/20/2000 | CA2358662A1 Therapeutic compositions for metabolic bone disorders or bone metastases |
| 07/20/2000 | CA2356939A1 Modulation of systemic memory t cell trafficking |
| 07/20/2000 | CA2355374A1 1-heterocycle substituted diarylamines |
| 07/20/2000 | CA2349832A1 Benzenesulfonamide derivatives and their use as mek inhibitors |
| 07/20/2000 | CA2349467A1 Sulphohydroxamic acids and sulphohydroxamates and their use as mek inhibitors |
| 07/20/2000 | CA2349180A1 Anthranilic acid derivatives |
| 07/20/2000 | CA2348236A1 4-arylamino, 4-aryloxy, and 4-arylthio diarylamines and derivatives thereof as selective mek inhibitors |
| 07/19/2000 | EP1020461A2 Use of alkaline salts of the (-)-enantiomer of omeprazole |
| 07/19/2000 | EP1020460A2 The sodium salt of the (-)-enantiomer of omeprazole |
| 07/19/2000 | EP1019434A2 Inhibitors of metalloproteinases, their therapeutic use, and process for the production of the starting compound in their synthesis |
| 07/19/2000 | EP1019409A1 Poly(adp-ribose) polymerase ("parp") inhibitors, methods and pharmaceutical compositions for treating neural or cardiovascular tissue damage |
| 07/19/2000 | EP1019396A1 Novel cycloalkyl substituted imidazoles |
| 07/19/2000 | EP1019394A1 PYRAZOLE DERIVATIVES AS p38 KINASE INHIBITORS |
| 07/19/2000 | EP1019389A2 Epothilone derivatives |
| 07/19/2000 | EP1019387A1 Dihydrobenzofuran and related compounds useful as anti-inflammatory agents |
| 07/19/2000 | EP1019386A1 Reverse hydroxamate derivatives as metalloprotease inhibitors |
| 07/19/2000 | EP1019091A1 50 human secreted proteins |
| 07/19/2000 | EP1019078A1 Use of cartilage oligomeric matrix protein for the treatment of rheumatoid arthritis |
| 07/19/2000 | EP1019071A2 Random peptides that bind to gastro-intestinal tract (git) transport receptors and related methods |
| 07/19/2000 | EP1019062A1 Osteoblast-specific mitogens and drugs containing such compounds |
| 07/19/2000 | EP1019046A1 Protease inhibitors |
| 07/19/2000 | EP1019040A1 INHIBITION OF p38 KINASE ACTIVITY BY ARYL UREAS |
| 07/19/2000 | EP1019027A1 Implantable collagen-containing putty material |
| 07/19/2000 | CN1260795A Quaternary ammonium compounds as tachykinin antagenists |
| 07/19/2000 | CN1260784A Quinoline derivatives as PDEIV and INF inhibitors |
| 07/19/2000 | CN1260721A Use of cartilage oligeomeric matrix protein for treatment of rheumatoid |
| 07/19/2000 | CN1260199A Multifunction quick-effect health medicinal plaster |
| 07/19/2000 | CN1260197A Bone-calcium liquid protein and its preparation method |
| 07/19/2000 | CN1054516C Powdered medicine for treating traumatic injury |
| 07/18/2000 | US6090944 Alkanoic acid derivatives as αv integrin receptor antagonists |
| 07/18/2000 | US6090852 Matrix metalloprotease inhibitor |
| 07/18/2000 | US6090843 Benzothiophenes compounds which have useful pharmaceutical activity |
| 07/18/2000 | US6090782 Contacting hematopoietic cells with a stem cell proliferation inhibition amount of a peptide or polypeptide having specific amino acid sequence |
| 07/18/2000 | US6090579 Human SDR2 cDNA clone |
| 07/18/2000 | US6090544 Screening for compounds capable of activating osteogenic protein-1-responsive transcription activating element by transforming cell with dna of element linked to reporter gene, exposing cell to compound, determining gene expression |
| 07/18/2000 | US6090410 Dry mix formulation for bisphosphonic acids |
| 07/18/2000 | US6090382 Human antibodies that bind human TNFα |
| 07/18/2000 | CA2093927C Ligand-mediated immunofunctional hormone binding protein assay method |
| 07/13/2000 | WO2000040733A1 Human cyclic nucleotide pdes |